Yee Soo Chae

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Shanu Modi, William Jacot, Toshinari Yamashita et al. · New England Journal of Medicine · 2022 · 2.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Identification of Developmental Endothelial Locus-1 on Circulating Extracellular Vesicles as a Novel Biomarker for Early Breast Cancer Detection

Pyong-Gon Moon, Jeong‐Eun Lee, Young‐Eun Cho et al. · Clinical Cancer Research · 2015 · 221 citations

Medicine, Molecular Biology, Oncology +17

Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer

Pyong-Gon Moon, Jeong‐Eun Lee, Young‐Eun Cho et al. · Oncotarget · 2016 · 196 citations · Full text

Medicine, Cancer Biology, Oncology +16

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

Myung‐Ju Ahn, Kentaro Tanaka, Luis Paz‐Ares et al. · Journal of Clinical Oncology · 2024 · 182 citations · Full text

Medicine, Oncology, Pharmacology +9